Awiqli 2100 Unit

AWIQLI 2100 Unit Insulin Icodec is a subcutaneous solution designed for managing blood sugar levels in diabetes. This long-acting insulin offers a convenient once-weekly administration option.

AWIQLI 2100 Unit Insulin Icodec is primarily used for the management of type 2 diabetes in adults. It helps control blood sugar levels, which is essential for preventing complications associated with diabetes. This medication is often prescribed for individuals who require long-acting insulin to maintain stable glucose levels throughout the week.

Common effects of AWIQLI 2100 Unit Insulin Icodec may include mild injection site reactions, such as redness or itching. Some users might experience hypoglycemia, characterized by symptoms like dizziness or sweating, if blood sugar levels drop too low. It's important to monitor blood sugar levels regularly while using this medication.

AWIQLI 2100 Unit Insulin Icodec should be stored properly to maintain its effectiveness. It is crucial to follow the storage instructions provided by the manufacturer. Always use a new needle for each injection to prevent contamination. Consult a healthcare provider before starting this medication, especially if you have a history of low blood sugar or other medical conditions.

AWIQLI 2100 Unit Insulin Icodec may interact with other medications, including oral hypoglycemic agents and certain antihypertensive drugs. Alcohol consumption can also affect blood sugar levels and should be monitored carefully. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.